Download PDF
physioscience 2022; 18(02): 60-68
DOI: 10.1055/a-1546-2601
Originalarbeit

Einfluss von Bewegungstherapie auf sexuelle Dysfunktionen bei Patienten mit Prostatakarzinom als Begleitung (oder nach) medizinischer Tumorbehandlung – Ein systematisches Review

Influence of Exercise Therapy on Sexual Dysfunction in Prostate Cancer Patients due to Medical Tumor Treatment – A systematic review
Rebecca Böwe
1   Hochschule Fresenius, University of Applied Sciences, Fachbereich Gesundheit & Soziales, Köln, Deutschland
,
Josef Beuth
2   Institut zur wissenschaftlichen Evaluation naturheilkundlicher Verfahren an der Universität zu Köln, Köln, Deutschland
› Author Affiliations
› Further Information
    Permissions and Reprints

Zusammenfassung

Hintergrund Sexuelle Dysfunktionen sind Lebensqualität mindernde Nebenwirkungen von Standardtherapien bei Prostatakarzinom.

Ziel Diese Untersuchung erfasst den aktuellen wissenschaftlichen Kenntnisstand bezüglich Effektivität von Bewegungstherapie zur Kompensation sexueller Dysfunktionen in Folge von Standardtherapien bei Prostatakarzinom.

Methode Systematisches Review in Anlehnung an „Preferred Reporting Items for Systematic Reviews and Meta-Analyses“ (PRISMA). Die Literaturrecherche wurde von 2 unabhängigen Gutachter*innen in den Datenbanken Pubmed und PEDro durchgeführt. Eingeschlossen wurden Randomized Controlled Trials (RCT) mit dem American Society of Clinical Oncology (ASCO) Evidenzlevel I, die sexuelle Funktionen von Patienten mit standardtherapierten Prostatakarzinom unter Bewegungstherapie evaluieren.

Ergebnisse 17 Publikationen mit 1175 Patienten mit Prostatakarzinom erfüllten die Einschlusskriterien. 11 Studien berichten signifikante Verbesserungen der sexuellen Funktionen durch Bewegungstherapie.

Schlussfolgerung Da die Mehrzahl der Studien nicht vergleichbar war, ist keine generalisierte Aussage bezüglich der Wirksamkeit von Bewegungstherapie möglich. Weitere kontrollierte Studien sind unabdingbar, um den Einfluss von Bewegungstherapie auf sexuelle Dysfunktion bei Patienten mit Prostatakarzinom unter Standardtherapien aufzuzeigen.

Abstract

Background Sexual dysfunction is a distressing side effect of standard therapies in prostate cancer patients.

Objective This systematic review provides an actual overview at the influence of exercise therapy on sexual dysfunction due to standard therapies in prostate cancer patients.

Method A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The literature search was performed by 2 independent researchers using Medline/Pubmed and PEDro, additionally the reference lists. RCT with ASCO evidence level I were included, if inclusion criteria were fulfilled.

Results The publications analyzed included 17 studies with 1175 patients. 11 of those studies document significant improvement of sexual dysfunction.

Conclusion Since most of the studies were not comparable, no generalized statement concerning the benefit of exercise therapy to improve sexual dysfunction in prostate cancer patients is possible. Further controlled studies on the impact of exercise training to improve sexual dysfunction in prostate cancer patients are warranted.

Schlüsselwörter

Prostatakarzinom - Bewegungstherapie - Beckenbodentraining - sexuelle Dysfunktion

Key words

prostate carcinoma - exercise therapy - pelvic floor training - sexual dysfunction

Supplement



Publication History

Received: 15 June 2021

Accepted: 29 October 2021

Article published online:
20 December 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Torre LA, Bray F, Siegel RL. et al. Global cancer statistics. CA Cancer J Clin 2015; 65: 87-108
    CrossrefPubMedGoogle Scholar
  • 2 Sanda MG, Dunn RL, Michalski J. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-1261
    CrossrefPubMedGoogle Scholar
  • 3 Reese JB. Coping with sexual concerns after cancer. Curr Opin Oncol 2011; 23: 313-321
    CrossrefPubMedGoogle Scholar
  • 4 Bober SL, Varela VS. Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol 2012; 30: 3712-3719
    CrossrefPubMedGoogle Scholar
  • 5 Higano CS. Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer. J Clin Oncol 2012; 30: 3720-3725
    CrossrefPubMedGoogle Scholar
  • 6 Lehto US, Tenhola H, Taari K. et al. Patients’ perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey. Br J Cancer 2017; 116: 864-873
    CrossrefPubMedGoogle Scholar
  • 7 Hamilton K, Chambers SK, Legg M. et al. Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer. Support Care Cancer 2015; 23: 133-142
    CrossrefPubMedGoogle Scholar
  • 8 Sanchez Varela V, Zhou ES, Bober SL. Management of sexual problems in cancer patients and survivors. Curr Probl Cancer 2013; 37 (06) 319-352
    CrossrefPubMedGoogle Scholar
  • 9 Morreale MK. The Impact of Cancer on Sexual Function. In: Sexual Dysfunction. Beyond the Brain – Body Connection. Adv Psychosom Med 2011; 31: 72-82
    CrossrefPubMedGoogle Scholar
  • 10 McCabe MP, Sharlip ID, Atalla E. et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine. J Sex Med 2016; 13 (02) 135-143
    CrossrefPubMedGoogle Scholar
  • 11 Rösing D, Klebingat K-J, Berberich HJ. et al. Male sexual dysfunction: diagnosis and treatment from a sexological and interdisciplinary perspective. Dtsch Ärztebl Int 2009; 106 (50) 821-828
    PubMedGoogle Scholar
  • 12 Miles CL, Candy B, Jones L. et al Interventions for sexual dysfunction following treatments for cancer. Cochr Database Syst Rev 2007; 4: CD005540
    PubMedGoogle Scholar
  • 13 Levinson AW, Ward NT, Sanda MG. et al. Comparison of Validated Instruments Measuring Sexual Function in Men. UROLOGY 2010; 76: 380-386
    CrossrefPubMedGoogle Scholar
  • 14 Mishra SI, Scherer RW, Geigle PM. et al. Exercise interventions on health-related quality of life for cancer survivors. Cochr Database Syst Rev 2010; 8: CD007566
    PubMedGoogle Scholar
  • 15 Mishra SI, Scherer RW, Snyder C. et al. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochr Database Syst Rev 2012; 8: CD008465
    PubMedGoogle Scholar
  • 16 Pennington KP, McTiernan A. The role of physical activity in breast and gynecologic cancer survivorship. Gynecol Oncol 2018; 149: 198-204
    CrossrefPubMedGoogle Scholar
  • 17 Baumann FT, Zopf EM, Bloch W. Clinical exercise interventions in prostate cancer patients – a systematic review of randomized controlled trials. Supp Care Cancer 2012; 20: 221-233
    CrossrefPubMedGoogle Scholar
  • 18 Dahn JR, Penedo FJ, Molton I. et al. Physical activity and sexual functioning after radiotherapy for prostate cancer: beneficial effects for patients undergoing external beam radiotherapy. J Urol 2005; 65: 953-958
    CrossrefPubMedGoogle Scholar
  • 19 Santa Mina D, Guglietti CL, Alibhai SM. et al. The effect of meeting physical activity guidelines for cancer survivors on quality of life following radical prostatectomy for prostate cancer. J Cancer Surviv 2014; 8: 190-198
    CrossrefPubMedGoogle Scholar
  • 20 Phillips SM, Stampfer MJ, Chan JM. et al. Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professional’s follow-up study. J Cancer Surviv 2015; 9: 500-511
    CrossrefPubMedGoogle Scholar
  • 21 Shin W-K, Song S, Jung S-Y. et al. The association between physical activity and health-related quality of life among breast cancer survivors. Health Qual Life Outcomes 2017; 15: 132
    CrossrefPubMedGoogle Scholar
  • 22 Karvinen KH, Courneya KS, North S. et al. Associations between exercise and quality of life in bladder cancer Survivors: a population-based study. Cancer Epidem Biomar 2007; 16: 984-890
    CrossrefPubMedGoogle Scholar
  • 23 Smits A, Smits E, Lopes A. et al. Body mass index, physical activity and quality of life of ovarian cancer survivors: time to get moving?. Gynecol Oncol 2015; 139: 148-154
    CrossrefPubMedGoogle Scholar
  • 24 Cormie P, Newton RU, Taaffe DR. et al. Exercise therapy for sexual dysfunction after prostate cancer. Nat Rev Urol 2013; 10: 731-736
    CrossrefPubMedGoogle Scholar
  • 25 Edmunds K, Tuffaha H, Scuffham P. et al. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review. Support. Care Cancer 2020; 28: 5661-5671
    CrossrefPubMedGoogle Scholar
  • 26 Awick EA, Phillips SM, Lloyd GR. et al. Physical activity, self-efficacy and self-esteem in breast cancer survivors: a Panel Model. Psycho-Oncology 2017; 26: 1625-1631
    CrossrefPubMedGoogle Scholar
  • 27 Liberati A, Altman DG, Tetzlaff J. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6: e1000100 DOI: 10.1371/journal.pmed.1000100.
    CrossrefPubMedGoogle Scholar
  • 28 Cochrane Deutschland, Institut für Medizinische Biometrie und Statistik, Freiburg, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften-Institut für Medizinisches Wissensmanagement, Ärztliches Zentrum für Qualität in der Medizin, Hrsg. Manual zur Bewertung des Biasrisikos in Interventionsstudien. 2. Aufl. 2021. Im Internet (Stand: 30.10.2021): www.leitlinien.de/methodik/pdf/manual-bewertung-v2-0.pdf
    PubMedGoogle Scholar
  • 29 Runowicz CD, Leach CR, Henry NL. et al. Breast cancer survivorship care guideline. J Clin Oncol 2016; 34: 611-635
    CrossrefPubMedGoogle Scholar
  • 30 Hegenscheid S, Harth A, Scherfer E. PEDro-Skala – Deutsch (2010). Im Internet (Stand: 30.10.2021): https://pedro.org.au/wp-content/uploads/PEDro_scale_german.pdf
    PubMedGoogle Scholar
  • 31 Armijo-Olivo S, da Costa BR, Cummings GG. et al. PEDro or cochrane to assess the quality of clinical trials? A meta-epidemiological study. PloS One 2015; 10: e0132634
    CrossrefPubMedGoogle Scholar
  • 32 Au D, Matthew AG, Alibhai SMH. et al. Pfilates and hypopressives for the treatment of urinary incontinence after radical prostatectomy: results of a feasibility randomized controlled trial. PM & R J 2020; 12: 55-63
    CrossrefPubMedGoogle Scholar
  • 33 Oh B, Kim JK, Lee H. et al. Effect of personalized extracorporeal biofeedback device for pelvic floor muscle training on urinary incontinence after robot-assisted radical prostatectomy: a randomized controlled trial. Neurourol Urodyn 2020; 39: 674-681
    CrossrefPubMedGoogle Scholar
  • 34 Milios JE, Ackland TR, Green DJ. Pelvic floor muscle training and erectile dysfunction in radical prostatectomy: a randomized controlled trial investigating a non-invasive addition to penile rehabilitation. Sex Med 2020; 8: 414-421
    CrossrefPubMedGoogle Scholar
  • 35 De Lira GHS, Fornari A, Cardoso LF. et al. Effects of perioperative pelvic floor muscle training on early recovery of urinary continence and erectile function in men undergoing radical prostatectomy: a randomized clinical trial. Int Braz J Urol 2019; 45: 1196-1203
    CrossrefPubMedGoogle Scholar
  • 36 Geraerts I, Van Poppel H, Devoogdt N. et al. Pelvic floor muscle training for erectile dysfunction and climacturia 1 year after nerve sparing radical prostatectomy: a randomized controlled trial. Int J Impot Res 2016; 28: 9-13
    CrossrefPubMedGoogle Scholar
  • 37 Jones LW, Hornsby WE, Freedland SJ. et al. Effects of nonlinear aerobic training on erectile dysfunction and cardiovascular function following radical prostatectomy for clinically localized prostate cancer. Eur Urol 2014; 65: 852-855
    CrossrefPubMedGoogle Scholar
  • 38 Lin Y-H, Yu T-J, Lin VC-H. et al. Effects of early pelvic-floor muscle exercise for sexual dysfunction in radical prostatectomy recipients. Cancer Nurs 2012; 35: 106-114
    CrossrefPubMedGoogle Scholar
  • 39 Nilssen SR, Mørkved S, Overgård M. et al. Does physiotherapist-guided pelvic floor muscle training increase the quality of life in patients after radical prostatectomy? A randomized clinical study. Scand J Urol Nephrol 2012; 46: 397-404
    CrossrefPubMedGoogle Scholar
  • 40 Prota C, Gomes CM, Ribeiro LHS. et al. Early postoperative pelvic-floor biofeedback improves erectile function in men undergoing radical prostatectomy: a prospective, randomized, controlled trial. Int J Impot Res 2012; 24: 174-178
    CrossrefPubMedGoogle Scholar
  • 41 Galvão DA, Taaffe DR, Chambers SK. et al. Exercise intervention and sexual function in advanced prostate cancer: a randomised controlled trial. BMJ Supp Palliat Care 2020; DOI: 10.1136/bmjspcare-2020-002706.
    CrossrefPubMedGoogle Scholar
  • 42 Lyons KS, Winters-Stone KM, Bennett JA. et al. The effects of partnered exercise on physical intimacy in couples coping with prostate cancer. Health Psychol 2016; 35: 509-513
    CrossrefPubMedGoogle Scholar
  • 43 Mardani A, Razi SP, Mazaheri R. et al. Effect of the exercise programme on the quality of life of prostate cancer survivors: a randomized controlled trial. Int J Nurs Pract 2020; 27: e12883
    CrossrefPubMedGoogle Scholar
  • 44 Hojan K, Kwiatkowska-Borowczyk E. et al. Inflammation, cardiometabolic markers, and functional changes in men with prostate cancer. A randomized controlled trial of a 12-month exercise program. Pol Arch Intern Med 2017; 127: 25-35
    PubMedGoogle Scholar
  • 45 Dieperink KB, Johansen C, Hansen S. et al. The effects of multidisciplinary rehabilitation: RePCa-a randomised study among primary prostate cancer patients. Br J Cancer 2013; 109: 3005-3013
    CrossrefPubMedGoogle Scholar
  • 46 Ben-Josef AM, Chen J, Wileyto P. et al. Effect of Eischens yoga during radiation therapy on prostate cancer patient symptoms and quality of life: a randomized phase II trial. Int J Radiat Oncol Biol Phys 2017; 98: 1036-1044
    CrossrefPubMedGoogle Scholar
  • 47 Cormie P, Galvão DA, Spry N. et al. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int 2015; 115: 256-266
    CrossrefPubMedGoogle Scholar
  • 48 Cormie P, Newton RU, Taaffe DR. et al. Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial. Prostate Cancer Prostatic Dis 2013; 16: 170-175
    CrossrefPubMedGoogle Scholar
  • 49 World Health Organization. Regional Office for Europe, Hrsg. Steps to health: a European framework to promote physical activity for health. Copenhagen: WHO Regional Office for Europe; 2007. Im Internet (Stand: 30.10.2021): www.who.int/iris/handle/10665/107830
    Google Scholar
  • 50 Bourke L, Smith D, Steed L. et al. Exercise for men with prostate cancer: A systematic review and meta-analysis. Eur Urol 2016; 69: 693-703
    CrossrefPubMedGoogle Scholar
  • 51 Buffart LM, Galvão DA, Brug J. et al. Evidence-based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions. Cancer Treat Rev 2014; 40: 327-340
    PubMedGoogle Scholar
  • 52 Denlinger CS, Sanft T, Baker KS. et al. Survivorship. Version 2.2017: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017; 15: 1140-1163
    CrossrefPubMedGoogle Scholar
  • 53 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF), Hrsg. Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Langversion 5.0, AWMF Registernummer: 043/022OL (2018). Im Internet (Stand: 30.10.2021): www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Prostata_5_0 / LL_Prostata_Langversion_5.0.pdf
    PubMedGoogle Scholar
  • 54 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF), Hrsg. S3-Leitlinie Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms, Langversion Version 4.1, AWMF Registernummer: 032-045OL (2018). Im Internet (Stand: 30.10.2021): www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Mammakarzinom_4_0 / Version_4.1/LL_Mammakarzinom_Langversion_4.1.pd
    PubMedGoogle Scholar
  • 55 Schmitz KH, Courneya KS, Matthews C. et al. American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010; 42: 1409-1426
    CrossrefPubMedGoogle Scholar
  • 56 Buffart LM, Galvão DA, Brug J. et al. Evidence-based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions. Cancer Treat Rev 2014; 40: 327-340
    CrossrefPubMedGoogle Scholar